This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Costamare Inc. (CMRE) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Costamare (CMRE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Costamare (CMRE) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Costamare (CMRE) delivered earnings and revenue surprises of 1.15% and 3.81%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Costamare (CMRE) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
High fuel costs are likely to hurt Costamare's (CMRE) Q322 results.
Textainer Group (TGH) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Textainer (TGH) delivered earnings and revenue surprises of 9.33% and 0.45%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Costamare (CMRE) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Costamare (CMRE) closed at $9.64, marking a +0.73% move from the previous day.
Costamare Inc. (CMRE) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Zacks.com users have recently been watching Costamare (CMRE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Costamare (CMRE) Stock Moves -0.23%: What You Should Know
by Zacks Equity Research
In the latest trading session, Costamare (CMRE) closed at $8.78, marking a -0.23% move from the previous day.
Should Value Investors Buy Costamare (CMRE) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Best Value Stocks to Buy for September 22nd
by Zacks Equity Research
CMRE, STLA and TRTN made it to the Zacks Rank #1 (Strong Buy) value stocks list on September 22, 2022.
New Strong Buy Stocks for September 22nd
by Zacks Equity Research
STLA, CMRE, TRTN, GWW, and CTS have been added to the Zacks Rank #1 (Strong Buy) List on September 22, 2022.
2 Dividend-Paying Shipping Stocks That Ensure Steady income
by Sanjana Goswami
Dividend-growth shipping stocks like Costamare (CMRE) and Genco (GNK) are in investors' good books for the handsome rewards they provide, especially in the current uncertain scenario.
Why Costamare (CMRE) is a Top Dividend Stock for Your Portfolio
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Costamare (CMRE) have what it takes? Let's find out.
Costamare (CMRE) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Costamare (CMRE) closed at $11.09 in the latest trading session, marking a -1.68% move from the prior day.
Are Options Traders Betting on a Big Move in Costamare (CMRE) Stock?
by Zacks Equity Research
Investors need to pay close attention to Costamare (CMRE) stock based on the movements in the options market lately.
Costamare (CMRE) is a Top Dividend Stock Right Now: Should You Buy?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Costamare (CMRE) have what it takes? Let's find out.
Costamare (CMRE) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Costamare (CMRE) delivered earnings and revenue surprises of 9.20% and 0.70%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Can Costamare (CMRE) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
Costamare (CMRE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Costamare (CMRE) Earnings Expected to Grow: What to Know Ahead of Q2 Release
by Zacks Equity Research
Costamare (CMRE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
This is Why Costamare (CMRE) is a Great Dividend Stock
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Costamare (CMRE) have what it takes? Let's find out.
Best Value Stocks to Buy for July 19th
by Zacks Equity Research
PBR, MATX, and CMRE made it to the Zacks Rank #1 (Strong Buy) value stocks list on July 19, 2022.
New Strong Buy Stocks for July 19th
by Zacks Equity Research
E, MATX, CMRE, PBR, and ARCB have been added to the Zacks Rank #1 (Strong Buy) List on July 19, 2022.
Are Options Traders Betting on a Big Move in Costamare (CMRE) Stock?
by Zacks Equity Research
Investors need to pay close attention to Costamare (CMRE) stock based on the movements in the options market lately.
Costamare (CMRE) Q1 Earnings Surpass Estimates
by Zacks Equity Research
Costamare (CMRE) delivered earnings and revenue surprises of 2.44% and 0.25%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Genco Shipping (GNK) Stock Jumps 8.6%: Will It Continue to Soar? (Revised)
by Zacks Equity Research
Genco Shipping (GNK) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Genco Shipping (GNK) Stock Jumps 8.6%: Will It Continue to Soar? (Revised)
by Zacks Equity Research
Genco Shipping (GNK) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.